These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10604568)

  • 21. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
    Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
    J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.
    Watson MW; Jaksic A; Price P; Cheng W; McInerney M; French MA; Fisher S; Lee S; Flexman JP
    J Infect Dis; 2003 Nov; 188(10):1533-6. PubMed ID: 14624379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.
    Dolganiuc A; Chang S; Kodys K; Mandrekar P; Bakis G; Cormier M; Szabo G
    J Immunol; 2006 Nov; 177(10):6758-68. PubMed ID: 17082589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.
    Langhans B; Braunschweiger I; Schweitzer S; Jung G; Inchauspé G; Sauerbruch T; Spengler U
    Immunology; 2001 Apr; 102(4):460-5. PubMed ID: 11328380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection.
    Hyodo N; Nakamura I; Imawari M
    Clin Exp Immunol; 2004 Mar; 135(3):462-6. PubMed ID: 15008979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.
    Fang SH; Chiang BL; Wu MH; Iba H; Lai MY; Yang PM; Chen DS; Hwang LH
    J Clin Microbiol; 2001 Nov; 39(11):3895-901. PubMed ID: 11682504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation.
    Langhans B; Lechmann M; Ihlenfeldt H; Jung G; Giers G; Schweitzer S; El Bakri M; Sauerbruch T; Spengler U
    Eur J Med Res; 2000 Mar; 5(3):115-20. PubMed ID: 10756165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
    Hu GJ; Wang RY; Han DS; Alter HJ; Shih JW
    Vaccine; 1999 Aug; 17(23-24):3160-70. PubMed ID: 10462252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
    Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
    Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.
    Wong DK; Dudley DD; Dohrenwend PB; Lauer GM; Chung RT; Thomas DL; Walker BD
    J Virol; 2001 Feb; 75(3):1229-35. PubMed ID: 11152496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.
    Lasarte JJ; García-Granero M; López A; Casares N; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    Hepatology; 1998 Sep; 28(3):815-22. PubMed ID: 9731578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis.
    Anthony DD; Post AB; Valdez H; Peterson DL; Murphy M; Heeger PS
    Clin Immunol; 2001 May; 99(2):232-40. PubMed ID: 11318595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
    Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
    Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Infect Dis; 2010 Sep; 202(6):853-61. PubMed ID: 20677943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.